34839 Game-changer or flop: Teprotumumab may not provide lasting improvement of pretibial myxedema
Publication
, Conference
Emge, DA; Nicholas, MW
Published in: Journal of the American Academy of Dermatology
September 2022
Duke Scholars
Published In
Journal of the American Academy of Dermatology
DOI
ISSN
0190-9622
Publication Date
September 2022
Volume
87
Issue
3
Start / End Page
AB169 / AB169
Publisher
Elsevier BV
Related Subject Headings
- Dermatology & Venereal Diseases
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Emge, D. A., & Nicholas, M. W. (2022). 34839 Game-changer or flop: Teprotumumab may not provide lasting improvement of pretibial myxedema. In Journal of the American Academy of Dermatology (Vol. 87, pp. AB169–AB169). Elsevier BV. https://doi.org/10.1016/j.jaad.2022.06.706
Emge, Drew A., and Matilda W. Nicholas. “34839 Game-changer or flop: Teprotumumab may not provide lasting improvement of pretibial myxedema.” In Journal of the American Academy of Dermatology, 87:AB169–AB169. Elsevier BV, 2022. https://doi.org/10.1016/j.jaad.2022.06.706.
Emge DA, Nicholas MW. 34839 Game-changer or flop: Teprotumumab may not provide lasting improvement of pretibial myxedema. In: Journal of the American Academy of Dermatology. Elsevier BV; 2022. p. AB169–AB169.
Emge, Drew A., and Matilda W. Nicholas. “34839 Game-changer or flop: Teprotumumab may not provide lasting improvement of pretibial myxedema.” Journal of the American Academy of Dermatology, vol. 87, no. 3, Elsevier BV, 2022, pp. AB169–AB169. Crossref, doi:10.1016/j.jaad.2022.06.706.
Emge DA, Nicholas MW. 34839 Game-changer or flop: Teprotumumab may not provide lasting improvement of pretibial myxedema. Journal of the American Academy of Dermatology. Elsevier BV; 2022. p. AB169–AB169.
Published In
Journal of the American Academy of Dermatology
DOI
ISSN
0190-9622
Publication Date
September 2022
Volume
87
Issue
3
Start / End Page
AB169 / AB169
Publisher
Elsevier BV
Related Subject Headings
- Dermatology & Venereal Diseases
- 3202 Clinical sciences
- 1103 Clinical Sciences